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INTRODUCTION
In the last decade, preimplantation genetic diagnosis (PGD)
has become an important alternative to prenatal diagnosis
for couples at high risk of transmitting inherited disorders
to their children. Fluorescence in situ hybridization (FISH)
has been offered for gender selection in X-linked diseases (1,
2), chromosomal translocations (3-5), aneuploidy, and recur-
rent implantation failure (6, 7). Procedures using polymerase
chain reaction (PCR) has been applied for single gene defects
including X-linked diseases (8-11).
Ornithine transcarbamylase (OTC; EC 2.1.3.3) is placed
in the mitochondrial matrix where it contributes to the detox-
ification of nitrogenous wastes through the urea cycle, and
catalyzes the synthesis of citruline from carbamyl phosphate
and ornithine. The OTC gene is located on the short arm of
the X chromosome within band Xp21.1 (12). It spans 73
kb, has an open reading frame of 1,062 nucleotides, and con-
tains 10 exons and 9 introns (13, 14). OTC deficiency (MIM-
#311250) is an X-linked and co-dominant metabolic disor-
der with partial penetrance in females (15). The phenotype
of OTC deficiency is extremely heterogeneous, ranging from
asymptomatic adult hemizygous males to acute neonatal
hyperammonemic coma in the first week of affected male
babies. Approximately 80% of heterozygous females are asy-
mptomatic and remaining 20% show clinical severity simi-
lar to males with partial deficiencies (16, 17). There are more
than 341 mutations known to cause OTC deficiency, all of
which are specific for the individual families. Mutations have
been found in all exons and introns with a relative paucity
of mutations in the sequence encoding the leader peptide
(exon 1 and a part of exon 2) and in exon 7 (17, 18).
To our knowledge, only two cases have been reported where
specific PGD for OTC deficiency were carried out using mul-
tiplex or duplex-nested PCR assay and healthy babies devoid
of the OTC mutation were born (19, 20). In this study, we
describe the successful pregnancy and birth after PGD for
OTC deficiency with simultaneous analyses of FISH and du-
plex-nested PCR in Korea. We have applied a duplex-nested
PCR for the amplification of both the causative mutation and
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Preimplantation Genetic Diagnosis for Ornithine Transcarbamylase
Deficiency by Simultaneous Analysis of Duplex-nested PCR and 
Fluorescence In Situ Hybridization
: A Case Report 
Ornithine transcarbamylase (OTC) deficiency is an X-linked co-dominant disorder.
A couple, with a previous history of a neonatal death and a therapeutical termination
due to OTC deficiency, was referred to our center for preimplantation genetic diag-
nosis (PGD). The female partner has a nonsense mutation in the exon 9 of the OTC
gene (R320X). We carried out nested polymerase chain reaction (PCR) for R320X
mutation and fluorescence in situ hybridization (FISH) for aneuploidy screening.
Among a total of 11 embryos, two blastomeres per embryo from 9 embryos were
biopsied and analyzed by duplex-nested PCR and FISH, and one blastomere per
embryo from 2 embryos by only duplex-nested PCR. As a result of PCR and restric-
tion fragment length polymorphism analysis, four embryos were diagnosed as una-
ffected embryos having the normal OTC gene. Among these embryos, only one
embryo was confirmed as euploidy for chromosome X, Y and 18 by FISH analy-
sis. A single normal embryo was transferred to the mother, yielding an unaffected
pregnancy and birth of a healthy boy. Based on our results, PCR for mutation loci
and FISH for aneuploidy screening with two blastomeres from an embryo could
provide higher accuracy for the selection of genetically and chromosomally normal
embryos in the PGD for single gene defects.
Key Words : Preimplantation Genetic Diagnosis (PGD); Ornithine Transcarbamylase (OTC) Deficiency; Nest-
ed PCR; FISH; Single Gene Defects
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the Y chromosome specific Sry gene, and FISH for aneuploidy
screening of chromosome X, Y and 18. A healthy boy was
born by the transfer of only one unaffected normal embryo.
CASE REPORT
A couple was referred to our center after therapeutic ter-
mination of the second pregnancy following prenatal diag-
nosis for OTC deficiency. In the first pregnancy, a male baby
was born but died at 10 days after birth due to liver dysfunc-
tion accompanying hyperammonemia. Molecular genetic
analysis of the couple’s OTC gene was performed by PCR and
direct sequencing at Seoul Asan Hospital and revealed a sin-
gle base substitution (R320X) in the exon 9 of the female
partner. In the second pregnancy, the fetus was identified to
be an affected boy by PCR and direct sequencing on a chori-
onic villus sample, and the pregnancy was therapeutically
terminated. In order to avoid a pregnancy with an affected
baby, the couple was counseled for PGD in Cheil General
Hospital.
In order to determine the efficiency of single cell PCR and
allele drop-out (ADO) rate, primers used for the detection of
the causative mutation and Y chromosome specific Sry gene
were tested using single lymphocytes (Table 1). Ovarian stim-
ulation, in vitro fertilization, and blastomere biopsy were done
as previously described (4, 5). After the blastomere biopsy
procedure, the embryos were washed several times and trans-
ferred to the G2.2 medium (Vitrolife Sweden AB, Kungs-
backa, Sweden). Each blastomere was washed twice through
two drops of G2.2 medium and transferred into sterile 0.2
mL PCR tubes containing 5  L of alkaline lysis buffer. For
each embryo biopsied, blank negative controls were prepared
from the wash drops. The nested-duplex PCR analysis was
performed by previously described protocol (6). Mutation
analysis by restriction fragment length polynorphism (RFLP)
with BclI restriction enzyme was carried out only for positively
amplified PCR products of blastomeres. Another blastomere
from the same embryo was prepared for FISH. The FISH anal-
ysis for chromosome X, Y and 18 was done as previously des-
cribed and the manufacture’s protocol (4, 5). The embryos were
cultured under standard culture condition until the diagno-
sis was established. The embryos with the normal genotype
were selected and transferred on day 4 after fertilization. Am-
niocentesis was performed at 16 weeks of gestation to con-
firm the results of PGD. Postnatal genetic and physiologi-
cal diagnosis was also conducted.
All 10 exons and exon-intron boundaries of the OTC gene
Annealing 
temp. (°C)
Name Sequences (5′ →3′ )
Product
sizes 
(bp)
Ornithine trans-  CACTCTGCTCCTTTGTCTCT 62 319
carbamylase GTTGGAACCACACAAAGAAC
Exon 9
Ornithine trans- GGCCATGTGTGTTTTTAGAT 64 218
carbamylase GTCCACTTTCTGTTTTCTGC
Exon 9-nested
Sry GAATATTCCCGCTCTCCGGA 64 472
GCTGGTGCTCCATTCTTGAG
Table 1. Sequences of oligonucleotide primers and PCR con-
ditions for duplex-nested PCR for OTC deficiency 
M1234
319 bp
218 bp
178 bp
223 bp
96 bp
40 bp
Fig. 1. Identification of the maternal mutation (heterozygote type)
in exon 9 of the OTC gene. After digesting the PCR product with
BclI, the 319 or 218 bp PCR products of the affected mother were
digested into 223 and 96 bp (lane 1) and 178 and 40 bp products
(lane 4), respectively. The 40 bp product was hardly seen on an
agarose gel. Lane 1 and 4; the first and nested PCR products of
the affected mother, respectively, lane 2 and 3; BclI-digested pro-
ducts from the first PCR products of the father. M: molecular weight
marker.
Fig. 2. Results of agarose gel electrophoresis of the restriction fragment length polymorphism (RFLP) analysis with BclI restriction enzyme
in the preimplantation genetic diagnosis for ornithine transcarbamylase deficiency. In normal embryos (No. 1, 2, 3 and 8), the 218-bp PCR
products were not digested with BclI.
Em 1 2 3 4 6 7 8 9 10 11
218 bp
178 bp
Mother
Control
Mother
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were screened by PCR followed by direct DNA sequencing
analysis. The heterozygous OTC gene with R320X nonsense
mutation (CGA→TGA) and wild type was detected in the
exon 9 of the female partner by RFLP (Fig. 1) and direct sequ-
encing (data not shown). This R320X nonsense mutation
was associated with acute neonatal hyperammonemia in their
first pregnancy and reduced enzyme activity by 10-15% (21).
Male partner has a normal OTC gene.
The efficiency and accuracy of the duplex-nested PCR anal-
ysis were tested on single lymphocytes from the heterozygous
female partner and normal male partner. PCR on single lym-
phocytes resulted in 90.6% (58/64) amplification rate, where-
as none of the negative controls showed a positive band. ADO
was detected in 4 out of 30 lymphocytes (13.3%).
After ovarian hyperstimulation, a total of 18 oocytes were
retrieved and 17 oocytes were injected using intracytoplas-
mic sperm injection in order to prevent DNA contamination
from inseminated sperm. Among a total of 11 embryos, two
blastomeres per embryo from 9 embryos were biopsied and
simultaneously analyzed by duplex-nested PCR and FISH,
and one blastomere per embryo from 2 embryos by only du-
plex-nested PCR. As a result of duplex-nested PCR and RFLP
analysis with the BclI restriction enzyme, ten showed success-
ful amplification for the exon 9 of the OTC gene, and the
amplification rate was 90.9%, almost same as that of the sin-
gle lymphocyte test. There were two unaffected males, five
affected males, two unaffected females, and one heterozygous
female (Fig. 2 and Table 2). No amplification was detected
in any of the negative controls. On the other hand, out of
nine blastomeres analyzed by FISH, only six blastomeres were
identified as chromosomally normal embryos (Fig. 3, Table 2).
However, among total four unaffected embryos (embryo 1,
2, 3, and 8) diagnosed by PCR, only two embryos (embryo
3 and 8) were identified as chromosomally normal by FISH.
The other two embryos (embryo 1 and 2) were shown to have
trisomy 18 and monosomy 18, respectively. Only one male
embryo (embryo 8) was transferred, and another female unaf-
fected embryo (embryo 3) was cryopreserved at blastocyst
stage on day 5 after fertilization. This PGD cycle resulted in
a singleton pregnancy and the genotype of the fetus was con-
firmed to be a normal male by amniocentesis at 16 weeks of
gestation. A healthy boy of 2.8 kg was delivered at 36 weeks.
The genotype of the baby for the exon 9 of OTC gene and
level of ammonia were confirmed as normal. 
DISCUSSION
Most PGD cycles for X-linked disorders such as Duchenne
muscular dystrophy and fragile X syndrome involved the
selection of female embryos which were diagnosed as normal
or heterozygous. These gender selections were supported by
couples at risk of X-linked recessive conditions. However,
OTC deficiency is an X-linked and co-dominant disorder.
Some heterozygous females represent severe phenotypic abnor-
malities such as nausea, vomiting and ataxia. ADO for affect-
Plus (+) and minus (-) signs indicate whether a band was detected cor-
responding to the Sry gene. N.A. (not assayed) indicates that blastomere
was not available for FISH. In the table, transferred embryo is presented
with bold and italic characters.
PGD, preimplantation genetic diagnosis; OTC, ornithine transcarbamy-
lase; PCR, polymerase chain reaction; FISH, fluorescence in situ hybri-
dization.
No. of embryo 
(stage)
FISH
(X;Y;18)
Diagnosis
PCR
OTC exon 
9-RFLP
Sry
1 (8 cells) Normal - 3;0;3 Trisomy
2 (12 cells) Normal + 1;1;1 Monosomy 18
3 (8 cells) Normal - 2;0;2 Female unaffected
4 (8 cells) Mutant + 1;1;2 Male affected
5 (8 cells) Amplification failure + 1;0;1 No result
6 (8 cells) Mutant + 1;1;2 Male affected
7 (8 cells) Heterozygote - 2;0;2 Female heterozygote 
8 (8 cells) Normal + 1;1;2 Male unaffected
9 (8 cells) Mutant + 1;1;2 Male affected
10 (5 cells) Mutant + N.A. Male affected
11 (4 cells) Mutant + N.A. Male affected
Table 2. Summary of the results of the PGD for OTC deficiency
with simultaneous analysis of duplex nested PCR and FISH
Fig. 3. Results of the fluorescence in situ hybridization (FISH) anal-
ysis on the embryos diagnosed to be normal by PCR in the PGD
for OTC deficiency. Panels A-Dshow the photographs for the results
of FISH on the embryos No. 1, 2, 3, and 8 in Table II, respectively.
Aqua, green and orange signals indicate the presence of the chro-
mosome X, Y and 18 in the nucleus of the blastomeres, respec-
tively.
PGD, preimplantation genetic diagnosis; OTC, ornithine transcar-
bamylase; PCR, polymerase chain reaction
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ed allele could lead to yielding an affected heterozygous baby,
even if the female embryo was diagnosed as normal by PGD
for OTC deficiency. Gender selection with FISH for Y chro-
mosome-specific loci is more reliable because amplification
failure could occasionally occur in single cell PCR. Thus, our
protocol with PCR and FISH in this study provides higher
accuracy for the selection of genetically and chromosomally
normal embryos in the PGD for X-linked co-dominant de-
fects.
We applied duplex-nested PCR and FISH analysis in two
blastomeres from each embryo, which were more than 6-cell
stage. Biopsy of more than a quarter of blastomeres from each
embryo could interfere with developmental potential of em-
bryos. Thus, single blastomere biopsy was applied to less than
6-cell stage embryos in this study. Sequential PCR and FISH
analysis in one blastomere (cell recycling) was reported and
could be used to detect the aneuploidy, but the rate of ADO
after PCR seems to be higher using this method (22, 23).
Therefore, we carried out two methods separately on two
blastomeres. A duplex-nested PCR analysis was developed
for the simultaneous diagnosis of a R320X mutation and a
gender selection, and FISH analysis was used to detect ane-
uploidy for chromosome X, Y and 18. As a result of duplex
nested PCR and FISH analysis, concordant results have been
obtained from two blastomeres at the sex locus, and the am-
plification efficiency was 100% (9/9 except two blastomeres,
that were not analyzed by FISH analysis) for Sry. And the
amplification rate was 90.9% (10/11) for exon 9 of the OTC
gene. 
Several strategies have been developed to decrease ampli-
fication failure and ADO in single cell analysis of PGD. These
included the development of sequential first and second polar
body analysis (24), improvement of the PCR condition by
increasing the denaturation temperature and time (19), using
a more powerful lysis method (25-28) and the use of fluores-
cent PCR for mutations or linked markers and multiplex
PCR (29-32). As mentioned above, we have also endeavored
to optimize single cell PCR conditions, which included longer
initial denaturation time, higher denaturation temperature,
and the selection of Taq polymerase, the concentration of
MgCl2, and lysis methods. The incidence of ADO was 5-
15% in many PGD laboratories (27, 28). At a preliminary
experiment on single lymphocytes in this study, the ADO
rate for exon 9 of the OTC gene was about 13.0% when using
duplex-nested PCR. We could not absolutely exclude the
possibility of ADO in the diagnosis of unaffected female em-
bryo owing to the relatively higher ADO. Thus, FISH was
simultaneously applied for the aneuploidy screening and sex
selection to prevent the pregnancy of heterozygous female.
In this study, we report the successful PGD and delivery
of a healthy boy in a couple at risk of transmitting the OTC
deficiency. This was carried out by the simultaneous analy-
sis of the duplex-nested PCR for a R320X mutation in the
OTC gene underlying the OTC deficiency and Y chromo-
some-specific loci, and FISH for aneuploidy screening of chro-
mosome X, Y and 18. This strategy could provide higher
accuracy for the selection of genetically and chromosomally
normal embryos in PGD for single gene defects. 
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